Document is current
Any future updates will be listed below
-
Authors
Yun, Do Hyun
Plymale, Margaret A.
Oyler, Douglas R.
Slavova, Svetla S.
Davenport, Daniel L.
Roth, John Scott https://orcid.org/0000-0003-0332-7220
-
Funding
Funding for this research was provided by:
Bureau of Justice Assistance (2018-PM-BX-K051)
National Center for Advancing Translational Sciences (UL1TR001998)
- License Information
-
More Information
Article History
Received: 15 February 2023
Accepted: 21 March 2024
First Online: 12 April 2024
Declarations
:
: Dr. John Scott Roth discloses the following: grants from Beckton Dickinson & Company, Gore, and Advanced Medical Solutions (paid to institution); consulting for Beckton Dickinson & Company, Medtronic, and AbbVie (Allergan). Dr. Douglas R. Oyler discloses the following: consulting for Pharmerica, KY Hospital Association; honoraria from: American Society of Health System Pharmacists, University of Texas at Austin (2020), TRC HealthCare (2020); and grants from: NIH: UM1DA049406 (Co-Investigator, ongoing); FDA: HHSF223201810183C (Co-Investigator, completed); USDOJ: 2018-PM-BX-K051 (PI, ongoing); BJA-2017–11447 (Co-Investigator, completed); KY Cabinet for Health and Family Services. PON2 746 2000004006 (PI, completed), PON2 726 1900002839 (Co-Investigator, completed), PON2 729 1800000576 (Co-Investigator, completed). The other authors (Drs. Margaret A. Plymale, Daniel L. Davenport, and Svetla S. Slavova and Mr. Do Hyun (Daniel) Yun) have no conflicts of interest or financial ties to disclose.
